Health care utilization among adenosine-sensitive supraventricular tachycardia patients presenting to the emergency department

被引:7
作者
Dewland, Thomas A. [1 ]
Oesterle, Adam [2 ]
Stein, John [3 ]
Marcus, Gregory M. [2 ]
机构
[1] Oregon Hlth & Sci Univ, Knight Cardiovasc Inst, Portland, OR 97201 USA
[2] Univ Calif San Francisco, Div Cardiol, Dept Med, Electrophysiol Sect, 500 Parnassus Ave,M1180B, San Francisco, CA 94143 USA
[3] Univ Calif San Francisco, Dept Emergency Med, San Francisco, CA 94143 USA
关键词
Supraventricular tachycardia; SVT; Adenosine; Emergency department; Catheter ablation; Healthcare utilization; QUALITY-OF-LIFE; RADIOFREQUENCY CATHETER ABLATION; LONG-TERM; FLECAINIDE ACETATE; MEDICAL THERAPY; REENTRANT TACHYCARDIA; EFFICACY; SAFETY; TACHYARRHYTHMIAS; TRIAL;
D O I
10.1007/s10840-017-0259-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Although adenosine-sensitive supraventricular tachycardia (SVT) is generally curable, it remains an important cause of healthcare utilization. We sought to determine predictors of health care utilization among SVT patients presenting to the emergency department (ED). We studied consecutive patients evaluated in an urban, academic ED for adenosine-sensitive SVT. The primary study outcomes were (1) ambulance transportation to the index ED visit, (2) hospital admission from the index ED encounter, and (3) recurrent SVT-associated ED encounters. Among 100 patients with adenosine-sensitive SVT, 35 were transported to the ED by ambulance. Prior electrophysiologist evaluation was associated with a significant 87% reduced odds of ambulance utilization (OR 0.13, 95% CI 0.03-0.67, p = 0.015). A total of 62 patients were subsequently admitted to the hospital. All patients with coronary artery disease, diabetes, syncope, and wide complex SVT were admitted. Similarly, individuals with an elevated troponin had a significantly greater odds of hospital admission (OR 16.8, 95% CI 1.9-148.4, p = 0.011). After the index ED visit, 60 patients were seen by an electrophysiologist, and 47 underwent catheter ablation. Individuals treated with catheter ablation had a significant 75% reduction in the risk of a recurrent ED visit for SVT (HR 0.25, 95% CI 0.10-0.62, p = 0.003). Readily modifiable clinical factors, including a previous visit to an electrophysiologist and treatment with catheter ablation, are associated with reduced health care utilization among patients presenting to the ED with SVT.
引用
收藏
页码:103 / 109
页数:7
相关论文
共 24 条
  • [1] Efficacy and safety of out-of-hospital self-administered single-dose oral drug treatment in the management of infrequent, well-tolerated paroxysmal supraventricular tachycardia
    Alboni, P
    Tomasi, C
    Menozzi, C
    Bottoni, N
    Paparella, N
    Fucà, G
    Brignole, M
    Cappato, R
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (02) : 548 - 553
  • [2] FLECAINIDE ACETATE FAR PAROXYSMAL SUPRAVENTRICULAR TACHYARRHYTHMIAS
    ANDERSON, JL
    PLATT, ML
    GUARNIERI, T
    FOX, TL
    MASER, MJ
    PRITCHETT, ELC
    KAY, GN
    PLUMB, VJ
    EPSTEIN, AE
    BUBIEN, RS
    BHANDARI, AK
    LEON, C
    BRINKLEY, AM
    ROSIN, BL
    MCCABE, E
    DATORRE, S
    DEBORDE, R
    HAFFAJEE, C
    RUFINO, K
    DEGON, C
    WEBB, CR
    BIELINSKI, KA
    DUNBAR, D
    HEDGES, M
    FJELDOOSPERBECK, K
    GOMES, JA
    WINTERS, S
    PE, E
    FOSTER, JR
    WOELFEL, A
    CULLINANE, L
    MCCARTHY, EA
    CHRISTIE, LG
    CARLSON, KL
    ALPERT, BL
    FECIK, CM
    MORENO, F
    JOHNSON, L
    SUMMERS, K
    ELLENBOGEN, KA
    MARTIN, ML
    HART, WL
    FRIEDMAN, NJ
    NEUMANN, S
    LAIDLAW, JC
    STOLLINGS, L
    CULLEN, MT
    DONAHUE, PA
    HAHN, MA
    HAWKINSON, RW
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1994, 74 (06) : 578 - 584
  • [3] Radiofrequency catheter ablation versus medical therapy for initial treatment of supraventricular tachycardia and its impact on quality of life and healthcare costs
    Bathina, MN
    Mickelsen, S
    Brooks, C
    Jaramillo, J
    Hepton, T
    Kusumoto, FM
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1998, 82 (05) : 589 - 593
  • [4] FLECAINIDE ACETATE FOR LONG-TERM PREVENTION OF PAROXYSMAL SUPRAVENTRICULAR TACHYARRHYTHMIAS
    BENDITT, DG
    DUNNIGAN, A
    BUETIKOFER, J
    MILSTEIN, S
    [J]. CIRCULATION, 1991, 83 (01) : 345 - 349
  • [5] Effect of radiofrequency catheter ablation an health-related quality of life and activities of daily living in patients with recurrent arrhythmias
    Bubien, RS
    KnottsDolson, SM
    Plumb, VJ
    Kay, GN
    [J]. CIRCULATION, 1996, 94 (07) : 1585 - 1591
  • [6] Relationship of Myocardial Ischemia and Injury to Coronary Artery Disease in Patients With Supraventricular Tachycardia
    Bukkapatnam, Radhika Nandur
    Robinson, Melissa
    Turnipseed, Samuel
    Tancredi, Daniel
    Amsterdam, Ezra
    Srivatsa, Uma Narasimhan
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2010, 106 (03) : 374 - 377
  • [7] Catheter ablation of accessory pathways, atrioventricular nodal reentrant tachycardia, and the atrioventricular junction - Final results of a prospective, multicenter clinical trial
    Calkins, H
    Yong, P
    Miller, JM
    Olshansky, B
    Carlson, M
    Saul, JP
    Huang, SKS
    Liem, LB
    Klein, LS
    Moser, SA
    Bloch, DA
    Gillette, P
    Prystowsky, E
    [J]. CIRCULATION, 1999, 99 (02) : 262 - 270
  • [8] Serum troponin testing in patients with paroxysmal supraventricular tachycardia: outcome after ED care
    Carlberg, David J.
    Tsuchitani, Sarah
    Barlotta, Kevin S.
    Brady, William J.
    [J]. AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2011, 29 (05) : 545 - 548
  • [9] COBBE SM, 1995, CIRCULATION, V92, P2550
  • [10] SAFETY AND EFFICACY OF ORAL FLECAINIDE THERAPY IN PATIENTS WITH ATRIOVENTRICULAR REENTRANT TACHYCARDIA
    COCKRELL, JL
    SCHEINMAN, MM
    TITUS, C
    HELMY, I
    LANGBERG, JJ
    LEE, MA
    GRIFFIN, JC
    [J]. ANNALS OF INTERNAL MEDICINE, 1991, 114 (03) : 189 - 194